📰 Leukemia News
Page 133 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
January 30, 2023
A young lady on TikTok has revealed all about how urotherapy, or urine therapy, saved her husband's life. Her @holistic.happy.healthy account on the social media platform contains a video in [...]
January 26, 2023
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have illuminated how treatments for multiple myeloma and other aggressive blood cancers can lead to future malignancies, called therapy-related myeloid neoplasms (tMNs).
January 26, 2023
Some asparaginase drug brands are causing more harm than good in treating young children with leukemia.
January 26, 2023
Tonights eye on america to find out about the new health care benefits available. its all part of what the va secretary told us is the alarmest outreach in history to our veterans. andrew myatt was willing to give his life to >> our job was to find i.e.d.s, disarm them, or destroy them. >> odonnell: but the veteran never thought his army service would make him sick years later. >> the last thing youre thinking about is, you know, that the smoke i walk by or the solvents i put in my vehicle is go...
January 25, 2023
Systemic mastocytosis is widely underdiagnosed, and many more hematologic oncologists should be looking for it, say experts.
January 24, 2023
About 13,200 men and another 2,300 women in the United States over age 50 are estimated to have VEXAS syndrome, according to a new study led by researchers at NYU Grossman School of Medicine.
January 23, 2023
Another study has linked glyphosate, the primary chemical used by Monsanto in its Roundup herbicide, to increases in cancer as well as alterations to DNA and oxidative stress. The study, which [...]
January 20, 2023
The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
January 19, 2023
Two global Phase 3 trials in adult CLL patients demonstrated superior efficacy for BRUKINSA (zanubrutinib) in first-line and relapsed/refractory treatment settings BRUKINSA is the only BTKi to demonstrate
January 19, 2023
MHRA marketing authorizations follow recent European Commission marketing authorizations BRUKINSA is the only treatment authorized for MZL in Great Britain BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: